# Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

Study · id `cardio:ct-nct07011147` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07011147](<https://clinicaltrials.gov/study/NCT07011147>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07011147

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 240 participants.

## Technical summary

Registry record NCT07011147. Randomized; no masking; primary purpose treatment. Start 2026-01-16 (actual); primary completion 2027-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 240 participants (planned count; ClinicalTrials.gov record NCT07011147, source copy `cardio:ctgov-nct07011147-2026-06-11`, retrieved 2026-10-26)
- Started: 2026-01-16 (actual) (ClinicalTrials.gov record NCT07011147, source copy `cardio:ctgov-nct07011147-2026-06-11`, retrieved 2026-10-26)
- Primary completion: 2027-06-30 (anticipated) (ClinicalTrials.gov record NCT07011147, source copy `cardio:ctgov-nct07011147-2026-06-11`, retrieved 2026-10-26)
- Completion: 2029-04-01 (anticipated) (ClinicalTrials.gov record NCT07011147, source copy `cardio:ctgov-nct07011147-2026-06-11`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT07011147, source copy `cardio:ctgov-nct07011147-2026-06-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07011147-2026-06-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
- Acronym: PREPARE 4 AID
- Condition: Type 1 Diabetes (T1D)
- Condition: Type 2 Diabetes
- Condition: Diabetes, Autoimmune
- Condition: Diabetes Mellitus
- Condition: Diabetes Mellitus Type 2
- Condition: Diabetes Mellitus, Type I
- Condition: Diabetes, Type II
- Condition: Diabetes
- Condition: Diabetes Mellitus, Insulin-Dependent
- Condition: Diabetes Mellitus Type II
- Condition: Diabetes Type 2 on Insulin
- Intervention (Device): Bionic Pancreas
- Intervention (Other): Routine Care
- Lead sponsor: University of Colorado, Denver
- Lead sponsor class: OTHER
- Collaborator: Massachusetts General Hospital
- Collaborator class: OTHER
- Collaborator: Beta Bionics, Inc.
- Collaborator class: INDUSTRY
- Collaborator: Ann & Robert H Lurie Children's Hospital of Chicago
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: University of Colorado, Denver (`cardio:org-university-of-colorado-denver`)
- Registry lists this organization as a collaborator: Massachusetts General Hospital (`cardio:org-massachusetts-general-hospital`)

## Provenance

Content hash: 51f4391eea030bd970c78c92aac8f795a31bbe349cea27774b7a7e71c93b6595
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
